#Congenital Neurologic Anomalies Market | Explore Tumblr posts and blogs

credenceresearchdotblog · 6 months ago

Text

Global enteral feeding devices market is expected to develop at a compound annual growth rate (CAGR) of 5.20%, from its estimated USD 4551.32 million in 2023 to USD 7182.55 million in 2032.The enteral feeding devices market is experiencing significant growth, driven by a combination of factors such as the increasing prevalence of chronic diseases, rising geriatric population, and advancements in medical technology. These devices, crucial for delivering nutrition directly to the gastrointestinal tract of patients who cannot consume food orally, are becoming indispensable in clinical settings.

Browse the full report at https://www.credenceresearch.com/report/enteral-feeding-devices-market

Market Dynamics

Drivers

1. Increasing Prevalence of Chronic Diseases: The growing incidence of chronic conditions like cancer, neurological disorders, and gastrointestinal diseases necessitates long-term nutritional support. Enteral feeding devices provide a lifeline for these patients, ensuring they receive the required nutrients.

2. Aging Population: The global aging population is a significant market driver. Elderly individuals often face difficulties in swallowing, necessitating enteral feeding. With the proportion of older adults rising, the demand for these devices is set to increase.

3. Technological Advancements: Innovations in enteral feeding devices, such as the development of user-friendly, portable, and highly efficient devices, are propelling market growth. Advanced features like safety alarms, anti-clogging mechanisms, and easy-to-clean designs enhance the appeal of these devices.

4. Shift Towards Home Care: There is a growing trend towards home healthcare due to its cost-effectiveness and convenience. Enteral feeding devices designed for home use are witnessing increased adoption, contributing to market expansion.

Restraints

1. Complications and Risks: The use of enteral feeding devices is associated with certain risks, including infections, tube dislodgement, and blockages. These complications can deter their use, impacting market growth.

2. High Costs: The initial costs of enteral feeding devices and the expenses associated with their maintenance can be high, which may limit their adoption, particularly in low-income regions.

Market Segmentation

The enteral feeding devices market can be segmented based on product type, age group, end-user, and geography.

By Product Type

1. Enteral Feeding Pumps: These are the most commonly used devices due to their precision in nutrient delivery and ease of use. 2. Enteral Feeding Tubes: Including nasogastric tubes, gastrostomy tubes, and jejunostomy tubes, these are essential for direct nutrient delivery to the stomach or small intestine. 3. Administration Sets: These sets are crucial for the delivery of nutrients from the feeding pump to the patient. 4. Other Accessories: Including syringes, giving sets, and connectors, these accessories support the feeding process.

By Age Group

1. Pediatrics: Children with congenital anomalies or severe illnesses often require enteral feeding.

2. Adults: Adults with chronic diseases, neurological impairments, or post-surgical conditions represent a significant user base. 3. Geriatrics: The elderly population is a primary demographic for enteral feeding due to age-related health issues.

By End-User

1. Hospitals: The largest end-user segment, where enteral feeding devices are extensively used for inpatient care. 2. Home Care Settings: Growing rapidly due to the increasing preference for home-based care. 3. Ambulatory Care Centers: These centers utilize enteral feeding devices for outpatient procedures and short-term care.

Regional Analysis

The enteral feeding devices market is geographically diverse, with significant growth observed in North America, Europe, Asia-Pacific, and the rest of the world.

1. North America: Dominates the market due to the high prevalence of chronic diseases, advanced healthcare infrastructure, and substantial healthcare expenditure. 2. Europe: Follows closely with a well-established healthcare system and increasing awareness about enteral feeding benefits. 3. Asia-Pacific: Expected to witness the fastest growth due to improving healthcare infrastructure, rising geriatric population, and increasing healthcare expenditure. 4. Rest of the World: Includes regions with emerging markets showing potential growth due to improving healthcare services.

Future Prospects

The future of the enteral feeding devices market looks promising with ongoing technological advancements and increasing awareness about the benefits of enteral nutrition. Key players in the market are focusing on developing innovative products and expanding their geographical presence through strategic collaborations and acquisitions.

Key Players

Conmed Corporation

C.R.Bard

Cook Medical

Boston Scientific Corporation

Moog Inc.

Fresenius Kabi AG

Danone Medical Nutrition

Kimberly-Clark

Abbott Nutrition

B Braun Melsungen AG

Avanos Medical, Inc.

Cardinal Health

Applied Medical Technology, Inc.

Vygon India

Fidmi Medical

ALCOR Scientific

Amsino International, Inc.

Others

Segmentation

By Product Type

Enteral Feeding Tubes

Nasogastric Tubes (NG Tubes)

Nasojejunal Tubes (NJ Tubes)

Gastrostomy Tubes (G Tubes)

Jejunostomy Tubes (J Tubes)

Percutaneous Endoscopic Gastrostomy Tubes (PEG Tubes)

Percutaneous Endoscopic Jejunostomy Tubes (PEJ Tubes)

Others

Enteral Feeding Pumps

Gravity Feeding Sets

Syringe Pumps

Electric Feeding Pumps

Ambulatory Feeding Pumps

Others

Giving Sets

Enteral Syringes

Administration Reservoirs

Accessories (Extension Sets, Connectors, Caps, etc.)

By Age Group

Pediatric

Adult

By Application

Oncology

Gastroenterology

Neurology

Critical Care

Diabetes

Geriatrics

Others

By End User

Hospitals

Ambulatory Surgical Centers

Long-term Care Centers

Home Care Settings

Others

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/enteral-feeding-devices-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: [email protected]

Website: www.credenceresearch.com

0 notes

cognizance-market-research · 1 year ago

Text

Epilepsy Monitoring Devices Market to Reach $736.5 Million by 2030

Epilepsy is a neurological condition marked by abnormal brain activity, leading to seizures or episodes of unusual behavior, sensations, and even loss of consciousness. It can affect anyone regardless of age, gender, race, or cultural background.

Seizures can manifest in different ways. During an episode, some individuals may stare blankly for a short time, while others may experience continuous jerking of their limbs or legs. It’s worth noting that a single seizure does not always indicate epilepsy. A diagnosis typically requires at least two unprovoked seizures that occur at least 24 hours apart. Most people with epilepsy can control their seizures with medication or surgery, but some may require lifelong treatment. In some cases, seizures may eventually go away, and children may outgrow the condition with age.

The global epilepsy monitoring devices market was valued at US$ 502.8 Million in 2022 and is anticipated to reach US$ 736.5 Million by the end of 2030 with a CAGR of 4.9% from 2023 to 2030

Healthcare companies have developed devices such as bracelets, watches, anti-suffocation pillows, and mattress devices to help individuals with epilepsy and their families. These devices can track seizures and provide protection against serious side effects. It’s important to note that these devices do not treat the disorder but are effective in providing peace of mind. Epilepsy monitoring devices use electroencephalogram (EEG) devices to diagnose brain abnormalities, which is a non-invasive electrophysiological monitoring technique used to detect electrical activity in the brain..

Epilepsy Monitoring Devices Market to Recover Amid COVID-19 Pandemic:

COVID-19 is expected to exert a positive influence on the global demand for epilepsy monitoring devices, especially in its later stages, as individuals with epilepsy faced a heightened risk of mortality. This increased risk can be attributed to the surge in seizures and epilepsy cases among patients affected by COVID-19.

According to statistics released by the American Epilepsy Society (AES) in December 2021, individuals with epilepsy were approximately 1.5 times more likely to succumb to COVID-19 compared to other infected patients. These circumstances have underscored the importance of epilepsy monitoring equipment, which allows patients to seek timely treatment. Consequently, COVID-19 is anticipated to have a substantial impact on the growth of the market.

Request Sample Copy of this Report: https://cognizancemarketresearch.com/request/epilepsy-monitoring-devices-market/

Factors Driving the Growth of the Epilepsy Monitoring Devices Market in North America:

The prevalence of epilepsy is on the rise in North America due to various factors such as an aging population, traumatic brain injuries, congenital anomalies, and genetic factors. As a result, there is an increasing demand for epilepsy monitoring devices for diagnosis and continuous monitoring of the condition.

The market for epilepsy monitoring devices in North America is witnessing numerous technological advancements, including the development of portable and wearable devices, digital EEG systems, and telemedicine facilities, making it more user-friendly, accurate, and cost-effective.

The healthcare expenditure in North America is increasing due to government initiatives, insurance coverage, and growing awareness among people. This is leading to an increase in spending towards better healthcare facilities and contributing to the growth of the epilepsy monitoring devices market.

The favourable reimbursement policies for epilepsy diagnosis and treatment in North America are also contributing to the market’s growth. The government is recognizing the need for better healthcare facilities and providing financial aid to patients that require epilepsy monitoring devices.

There is an increase in awareness among patients and physicians in North America regarding the importance of continuous monitoring of epilepsy patients. This awareness is contributing to the growth of the epilepsy monitoring devices market as more physicians are recommending the use of these devices.

About Us

Cognizance market research is continuously guiding customers around the globe towards strategies for transformational growth. Today, businesses have to innovate more than ever before, not just to survive, but to succeed in the future. Customers choose cognizance market research not only to recognize growth opportunities but to help create visionary strategic initiatives for their futures, facilitated by our incredible depth and breadth of strategic leadership, study, resources, events, and expertise that help our customers to achieve their goals.

As the gold standard data provider to the world’s largest industries, to generate the most detailed, authoritative, and granular market information, cognizance market research continuously captures and analyzes terabytes of data. Our unique, human-driven, and technology-powered data-driven approach generates the optimistic, actionable, and forward-looking intelligence you need to forecast the future and avoid blind-spots. We give you access to unrivalled capabilities across one platform, leveraging our unique data, expert insight, and creative solutions.

Website - https://cognizancemarketresearch.com/

Facebook - http://facebook.com/cognizancemarketresearch

Youtube - https://www.youtube.com/@cognizancemarketresearch

Linkedin - https://www.linkedin.com/company/cognizance-market-research-cmr

Blog - https://creativemarketpr.com/

0 notes

apurvafmi-blog · 6 years ago

Link

Congenital Neurologic Anomalies are the birth defect of the physical structure of the brain and spinal cord. Congenital Neurologic Anomalies is caused by abnormal ontogenetic development of the fetus and occur during fetal intrauterine growth. There are different type of anomaly occurs by abnormal ontogenetic development such as malformation which is caused by abnormal development of the tissue and organ, Dysplasia is caused by the irregular arrangement of the cells, deformation is caused by abnormal physical force which damages tissue and organ and disruption also caused by a destructive process which affects organ and tissues. Anencephaly (Partial absence of the cranial vault), encephalocele (Herniation of the brain or meninges through a defect in the skull), spina bifida (Defects in the closure of the spinal column) are the most serious neurologic anomalies which are developed in the first two months of gestation. Congenital Neurologic Anomalies also occur by Teratogen which affects to normal ontogenic development during the fetal intrauterine growth and leads to Congenital Neurologic Anomalies. Genetic factor, environmental factor, and other factors also causes Congenital Neurologic Anomalies. Smoking, vitamins, Drugs, alcohol and other toxic substance infect the infant during fetal intrauterine growth. The neural tube usually fuses 18–26 days after ovulation and its defect lead Congenital Neurologic Anomalies. Congenital Neurologic Anomalies diagnosis is the only way to prevent anomalies or malformation before the development. There is two method involved in the diagnosis of Congenital Neurologic Anomalies. One is Invasive methods and another one is Noninvasive methods.

Globally increasing incidence and prevalence of Neurologic Anomalies and fetal infections are the major factors driving the growth of the Congenital Neurologic Anomalies market. Innovative new diagnosis techniques for Congenital Neurologic Anomalies such as Invasive and Noninvasive methods is expected to increase the acceptance of Congenital Neurologic Anomalies diagnosis market. Prenatal Ultrasonography or Targeted ultrasonography which is recommended by the expert for all pregnant woman, for the detection of Neurologic Anomalies such as short-limbed skeletal dysplasia and others, is anticipated to boost the growth of Congenital Neurologic Anomalies Market. Fetal chromosome abnormalities detection by the Noninvasive method also expected to contribute significantly to Congenital Neurologic Anomalies market growth. Apart from that other invasive method such as CVS, Cordocentesis, Fetoscopy, and fetal biopsy and biochemical screening with the help of maternal serum is also a growth factor for the Congenital Neurologic Anomalies market. The increasing demand for a customized Congenital Neurologic Anomalies diagnosis with the specifications and other imaging methods and these are the key factors anticipated to propel the demand for Congenital Neurologic Anomalies worldwide.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/26257

The Global Congenital Neurologic Anomalies market is segmented on the basis of Test type and by End user

Based on the Test type Congenital Neurologic Anomalies market is segmented as:

Invasive methods

Noninvasive methods

Amniocentesis

Chorionic villus sampling

Cordocentesis

Fetoscopy

Fetal biopsy

Biochemical screening

Ultrasound

Magnetic resonance

Based on the end user Congenital Neurologic Anomalies market is segmented as:

Hospitals

Clinics

Diagnostic and research laboratories

Others

Rapidly increasing Central nervous system malformations is the major driver in the Congenital Neurologic Anomalies market. The global Congenital Neurologic Anomalies market by Invasive method Test type is expected to be dominated by the Amniocentesisdue and Chorionic villus sampling to higher adoption by pregnant women for Congenital Neurologic Anomalies testing. By end user, Congenital Neurologic Anomalies market is expected to be dominated by Diagnostic and research laboratories and hospitals due to higher User footfall for the Congenital Neurologic Anomalies. The manufacturers in the Congenital Neurologic Anomalies market are focusing on manufacturing advanced technology for better patient compliance and make the procedure easier.

The global Congenital Neurologic Anomalies market is expected to be dominated by North America due to higher adoption of new technology and significant development in the reimbursement policies. Europe is expected to be the second most lucrative Congenital Neurologic Anomalies market due to rising government funds for research and high risk of chromosomal disorders with increasing maternal age. Asia-Pacific is expected to be the fastest growing Congenital Neurologic Anomalies market due to the rapidly growing incidence of late pregnancies. Latin America and Middle East & Africa is expected to be the least lucrative market due to Low awareness and government initiative and established healthcare infrastructure in Congenital Neurologic Anomalies market.

Request Report TOC@ https://www.persistencemarketresearch.com/toc/26257

Examples of some of the market participants in the global Congenital Neurologic Anomalies market identified are: Thermo Fisher Scientific, Inc, F. Hoffmann-La Roche AG, CooperSurgical, Inc, Bioarray S.L, Reproductive Health Science Ltd., SciGene Corporation, Agilent Technologies, Inc, Beijing Genomics Institute, Medline Industries, Medtronic, Becton, Dickinson and Company, Integra Lifesciences, and among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

ABOUT US:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: [email protected]

#Congenital Neurologic Anomalies Market

0 notes

myabhijitr · 6 years ago

Text

Tissue Engineering Market - Size, Share, Trends, and Forecast to 2026

Tissue Engineering is an interdisciplinary field addressed to develop functional three-dimensional tissues combining cells, scaffolds, and bioactive molecules. This field involves scientific areas such as cell biology, chemistry, material science, molecular biology, medicine, and engineering. It can be used to develop functional constructs that can be used to reestablish, maintain or improve the condition of injured body parts or tissues.

Get PDF Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2217

Tissue engineering also assist in regeneration of damaged tissues by combining cells from the body with highly porous scaffold biomaterials. Scaffold biomaterials act as templates for tissue regeneration and guide the growth of new tissue. Tissue regeneration is highly beneficial for clinical management of organ therapeutics such as organ transplantation. The source of cells utilized in tissue engineering can be autologous (from the patient), allogenic (from a human donor but not immunologically identical), or xenogenic (from a different species donor).

Tissue engineering is gaining traction in various areas such as wound care, burn treatment, orthopedics, neurology, urological products, and others. Tissue engineering can play an important role in the management of pediatric patients. Tissue or organs absent at the time of birth, in congenital anomalies such as bladder exstrophy, esophageal atresia, and congenital diaphragmatic hernia pose a serious challenges in surgical repair. Moreover, increasing burn and trauma related injuries are expected to drive the global tissue engineering market growth. According to the American Burn Association 2014 data, nearly 450,000 patients receive hospital and emergency room treatment for burns annually.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/2217

Shortage of donor for various transplantation procedures presents a severe challenge to clinicians worldwide. According to the U.S. government information on organ donation and transplantation, as of 2017 nearly 114,687 people in the U.S. were on waiting lists for transplants of kidneys, hearts, livers, and other organs. Tissue engineering can fulfil the inadequacy of organ transplantation and increasing 3D printing prominence in medical applications for regeneration is anticipated to propel the demand for tissue engineering during the forecast period. Tissue engineering also holds a promising future for the restoration of 3D contour as well as the loss of function for the affected body parts.

Currently available tissue engineering methods face several problems including ineffective cell growth, insufficient, and unstable production of growth factors to stimulate cell communication and proper response and lack of suitable biomaterials and techniques for capturing appropriate physiological architectures. Moreover, inability to control cellular functions and their various properties (biological, mechanical, electrochemical and others) and issues of biomolecular detection and biosensors are other limitations associated with tissue engineering.

Key players operating in the global tissue engineering market include Acelity L.P. Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet.

Click To Continue Reading On Tissue Engineering Market

#tissue engineering market #tissue engineering market size #tissue engineering market trends

0 notes

rajputdishank20-blog · 5 years ago

Text

Global Tissue Engineering Market by Applications and Regions – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2020 – 2026

Global tissue engineering market was valued at USD 9.9 billion in 2019 and is expected to reach USD 28.9 billion by 2026, expanding at a CAGR of around 14.2% during the forecast period, 2020 – 2026. Development of specialized procedures such as sterilization and implant fixing has helped in transformation of allogeneic implants in applications such as biostatic implants is a major factor which is fueling the growth of the market.

Market Drivers, Restraints, Opportunities, and Trends:

Rising demand from the cardiology and vascular application is driving the growth of the tissue engineering market in the forecasted period.

Due to increasing prevalence of musculoskeletal disorders orthopedics, musculoskeletal, and spine segment is set to have significant impact on the potential revenue hikes in the market.

Availability of private & government funding, heavy healthcare investments, and advanced technology required for diagnosis and treatment of chronic disorders have been a major boost for the growth of the market.

Surging demand for heart transplantation in children with congenital malformations such as single ventricle anomalies, is set to create lucrative opportunities for the market.

Treatment of neurological diseases is significant challenge which can be a retraining factor that can hinder the growth of the market.

Read More: https://dataintelo.com/report/tissue-engineering-market/

0 notes

marketnewsri · 5 years ago

Text

Tissue Engineering Market Analysis of Major Competitors and Their Strategies 2020-2027

June 01, 2020: The global tissue engineering market size is expected to reach USD 28.9 billion by 2027, expanding at a CAGR of 14.2%, according to a new report by Radiant Insights, Inc. Allogenic tissue transplant method efficiently addresses challenges and limitations regarding the implementation and availability of autologous transplants. Moreover, the development of specialized procedures including implant fixing and sterilization to transform allogeneic implants so for application as biostatic implants is expected to drive revenue generation in this market. Rapid advancements and a strong pipeline of regenerative medicine are anticipated to provide effective solutions for chronic conditions. Several companies in growing markets are striving to capitalize on the untapped market potential with a strong focus on R&D. For instance, RepliCel is investing in multiple regenerative medicine products. As of 2019, its three products (RCH-01, RCS-01, RCT-01) were in the development phase and its dermal injector device (RCI-02) is under pre-commercialization production and testing phase. Request a Free Sample Copy of this Report @ https://www.radiantinsights.com/research/tissue-engineering-market-2027/request-sample The application of nanotechnology has played a critical role in the process of tissue engineering. Treating neurological diseases is a significant challenge as early diagnosis and treatment initiation is crucial. However, the advent of new 3D designed nanofibers has proved to be a ready alternative to aid the regeneration of damaged neurons. Such advances have propelled the growth of tissue engineering products. Further key findings from the report suggest: • Cardiology and vascular application is one of the fastest-growing segments owing to an increasing incidence rate of heart failures worldwide • Since the past 20 years, cardiac cell therapy or cardiomyoplasty has been an important focal point of the majority of the studies aimed at heart disease management through regeneration • A rise in the number of children with congenital malformations such as single ventricle anomalies has led to the growing demand for heart transplantation • Tissue-engineered organs help address challenges related to the lack of suitable donor organ and potential side effects related to the transplantation, thereby driving the tissue engineering market growth • Orthopedic, musculoskeletal, and spine segment accounted for the major revenue share in 2019 and is anticipated to dominate the market for tissue engineering through 2027 • The high share is attributable to frequent damage to musculoskeletal tissues or loss of tissue in disease or injury with limited repair probability • In addition, a rise in geriatric population, increasing sports-related injuries, and musculoskeletal disorders is also responsible for a high share of orthopedic, musculoskeletal, and spine segment • The lucrative opportunities proposed by emerging economies have drawn the attention of global leaders for investing in the Asia Pacific region. This is attributable to the fastest growth of the market for tissue engineering in the Asia Pacific region throughout the forecast period Share, • Medtronic plc; Zimmer Biomet Holdings, Inc; Allergan plc; Athersys, Inc; ACell, Inc.; Stryker Corporation; Integra LifeSciences Corporation; and Baxter International, Inc. are the key players operating in the market for tissue engineering • These participants are engaged in strategic alliances, deals, and development of novel products to sustain their market share. Download Full Research Report @ https://www.radiantinsights.com/research/tissue-engineering-market-2027 About Radiant Insights: At Radiant Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Media Contact: Michelle Thoras. Corporate Sales Specialist Radiant Insights, Inc. Phone: +1-415-349-0054 Toll Free: 1-888-928-9744 Email: [email protected] Web: https://www.radiantinsights.com/

0 notes

megasddw-blog · 5 years ago

Text

Radiopharmaceutical Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2023

The Report of “Radiopharmaceutical Market” Research Future Covers the Information like Market, Prominent Players and Radiopharmaceutical Market Market Segmentation, Regional Outlook, End-User and Forecast to 2023.

Radiopharmaceuticals are radioisotopes used for the therapeutic and diagnosis purposes and play a crucial role in the medical diagnosis. Radiopharmaceutical can be used with imaging devices to study the dynamic processes taking place in various parts of the body. The global radiopharmaceutical market likely to attain USD 10,473.88 Mn at a CAGR of 8.7% over the forecast period of 2017-2023. The key factors influencing the growth of the global radiopharmaceutical market include the massive shift of the healthcare industry towards a personalized approach towards diagnosis and treatment.

Widespread prevalence of chronic diseases such as cancer, cardiovascular diseases and others have generated huge demand for treatment and diagnosis which has provided an impetus to the growth of the market. In addition, growing incidence rate of oncology diseases creates the need for cancer management which is anticipated to be plus for the growth of the global radiopharmaceutical market. On the other hand, risks associated with radiopharmaceuticals are expected to e hurdle to the growth of the global radiopharmaceutical market. Low feasibility of treatment and high costs of devices might also impede the growth of the market over the forecast period.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/1650

Competitive Landscape

The key players in the global radiopharmaceutical market include Medtronic, Canadian Nuclear Laboratories (CNL), Jubilant Life Sciences Ltd., Lantheus Medical Imaging, Inc., Bayer AG, Advanced Accelerator Applications S.A., Bracco Diagnostic Inc., Mallinckrodt Pharmaceuticals, General Electric Company (GE Healthcare), Cardinal Health Inc., IBA Dosimetry GmbH, Siemens AG, Nordion, Inc., Sun Pharmaceutical Industries Ltd., and Avid Radiopharmaceuticals.

Industry Updates

In January 2019, RadioMedix Inc., a biotechnology company focused on targeted radiopharmaceuticals and Curium, a leader in radiopharmaceuticals, announced that FDA has granted Fast Track designation to their diagnostic radiopharmaceutical, 64Cu-Dotatate.

Segmentation

The global radiopharmaceutical market has been segmented based on type, type of test, application, route of administration, and end user.

By type, the global radiopharmaceutical market has been segmented into diagnostic type radiopharmaceuticals and therapeutic type radiopharmaceuticals. The diagnostic type radiopharmaceutical segment has been further segmented into SPECT radiopharmaceutical and PET radiopharmaceutical. The SPECT radiopharmaceutical sub segment has been further segmented into Technetium-99m, Thallium-201, Iodine-123, and others. The PET radiopharmaceutical sub segment has been further segmented into F-18, Rubidium-82, and others.

The therapeutic type radiopharmaceutical segment has been further segmented into beta emitters, alpha emitters, brachytherapy. The beta emmiters sub-segment has been further segmented into Iodine-131, Yttrium-90, Samarium-153, Rhenium-186, Lutetium-177, and others. The brachytherapy sub segment has been further segmented into Iodine-125, Iridium-192, Cesium-131, and others.

By type of test, the global radiopharmaceutical market has been segmented into bone scan, white blood cell scan, myocardial perfusion scan, lung scan, parathyroid scans, hepatobiliary scans, gallium scan, renal nuclear medicine scan, cerebral perfusion scan and others. The bone scan segment has been further segmented into Technetium-99m 1st, fluoride-18 2nd, and others. The Myocardial Perfusion Scan segment has been further segmented into Technetium-99m, Thallium-201, Rubidium-82, and others. The lung scan segment has been further segmented into Xenon-133, Krypton-81m, and others. The white blood cell scan segment has been further segmented into Indium-111 and others.

By application, the global radiopharmaceutical market has been segmented into oncology, cardiology, neurology, urology, and others. The oncology segment has been further segmented into prostate cancer, bone cancer, breast cancer and others. The cardiology segment has been further segmented into coronary artery disease, cardiomyopathy and others. The neurology segment has been further segmented into traumatic brain injury, stroke, Alzheimer’s disease and others. The urology segment has been further segmented into acute pyelonephritis, congenital renal anomalies, and others.

By route of administration, the global radiopharmaceutical market has been segmented into oral, intravenous and others.

By end user, the global radiopharmaceutical market has been segmented into hospitals, diagnostic centres, research institutes and others.

Regional Analysis

By region, the global radiopharmaceutical market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas and Europe collectively account for the foremost share of the global market. High healthcare expenditure, robust healthcare sector and prevalence of chronic diseases in these regions such as cancer, coronary disorders, stroke among others are driving the market in theses region. High investment in R&D activities and presence of huge patient pool and market players augur the growth of these markets. The Americas is the larges market while Europe follows the Americas closely. APAC is poised to be the fastest growing market for radiopharmaceuticals. Expanding patient population base, surging prevalence of chronic diseases stimulate the growth of the market. High healthcare spending in the emerging economies of the region coupled with rising awareness which generate huge demand for diagnostics has fueled the growth of the market in the region.

Access Full Report at https://www.marketresearchfuture.com/reports/radio-pharmaceutical-market-1650

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: [email protected]

#Radiopharmaceutical Market

0 notes

lilywhiteflower-blog · 6 years ago

Text

Enteral Feeding Formulas Market - Recent Trends, Development, Growth & Forecast 2017-2025

Global Enteral Feeding Formulas Market: Snapshot

Enteral feeding implies a direct method of artificially inserting nutrients and supplements into the GI tract. All forms of tube feeding methods, including gastronomy, nasojejunal, nasogastric, and orogastric, are considered to be a part of enteral feeding methods. In most circumstances, children are in a greater need of enteral feeding due to several medical issues that render them to ingest foods in a natural manner. These reasons can include impaired swallowing, structural anomalies or abnormalities in the mouth or the esophagus, anorexia or other eating disorders, chronic illnesses, primary disease management, growth in overall bodily nutrient needs, or congenital abnormalities. Enteral feeding essentially stents the esophagus, allowing the administration of foods, nutrients, and supplements to the stomach by bypassing the mouth and the esophagus. Conversely, it also allows for a free passage for draining the contents in a stomach should the need arise.

Enteral feeding is a growing requirement among the rising geriatric population, and a lot of players providing enteral feeding formulas are accepting this change in order to grow in profitability. The number of elderly patients requiring enteral feeding has grown considerably over the recent past. Their nutritional requirements are different from the conventional formulas intended for children, which allows enteral feeding formulas for adults to be an entirely different market segment from the formulas used to feed children. Various types of enteral feeding formulas are being commercially sold across key regions, which include isolated nutrient sources, formulas for diabetics, and formulas high in fiber.

Request Sample Copy of the Report @

https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1169

Global Enteral Feeding Formulas Market: Overview

Enteral feeding gets the required nutrition containing carbohydrate, protein, fat, water, minerals, carbohydrate, and vitamins, directly to the stomach. In many cases, proper nutrition is not supplied to the body due to various reasons, here enteral feeding formulas plays a crucial role.

On the basis of products, the market can be classified into standard and disease-specific formulas. By stage, the global enteral feeding formulas market can be segmented into adults and pediatrics. In terms of application, the market can be divided into neurology, oncology, gastroenterology, diabetes, critical care, and other applications. Based on end user, the market can be categorized into hospitals and long-term care facilities. Long-term care facilities can be further segmented into nursing homes, homecare agencies, and assisted living facilities

The report offers a comprehensive overview of various factors contributing to the expansion of the global enteral feeding formulas market. It also provides insights into challenges that the market could face over the forecast period. The prevailing trends in overall market operations are also studied in the report in detail.

Request TOC of the Report @

https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1169

Global Enteral Feeding Formulas Market: Trends and Prospects

The growth of the global enteral feeding formulas market is driven by factors such as growing geriatric population, increase in various chronic diseases, and overall increase in healthcare expenditure.

In terms of product, the standard formulas segment held a large market share, and this segment is expected to grow in the forecast period as it is known to offer a complete and balanced nutrition. The specialized formulae segment is projected to grow faster in the said period due to the high demand for these products used by patients who face difficulty in digestion of complex proteins.

Based on stage, the adults market segment is expected to account for large share of the said market. Escalating large base of geriatric population in developed economies is one of the key reasons for high demand.

By application, the oncology segment is expected to largely contribute to the market. Due to due to high prevalence of malnutrition among the cancer patients, this segment will continue to lead in the years ahead. Hospitals, the end user segment of the market held a major share of the market. Vast use of inpatient services, such as surgical intervention, extended post-surgery stays, and intensive care are some of the key factors supplementing the growth of this segment.

Read Comprehensive Overview of Report @

https://www.tmrresearch.com/enteral-feeding-formulas-market

Global Enteral Feeding Formulas Market: Regional Analysis

Geographically, the global enteral feeding formulas market can be segmented into North America, Europe, Asia Pacific, and Rest of the World. Among the mentioned regions, North America is expected to lead the pack. Due to escalating rate of chronic diseases, large pool of geriatric population, coupled with large availability of home care service providers, this region is likely to continue contributing to the market growth over the forecast period.

Another promising regional market for feeding formulas is Asia Pacific. It is projected to account for a large market share during the said period. With rise in economic development of countries such as India, China, Philippines, and Indonesia, the per capita healthcare expenditure has also seen a tremendous increment. Numerous WHO and UNICEF initiatives to lower malnourishment, coupled with growth of medical tourism and better healthcare infrastructure have supplemented the growth of the market.

Global Enteral Feeding Formulas Market: Competitive Landscape

Some of the leading players in the global enteral feeding formulas market are Abbott Corporation, Global Health Products, Inc., Fresenius Kabi AG, Victus Mead Johnson & Company, LLC, Danone S.A, Hormel Food Corporation, Nestle S.A, B. Braun Melsungen AG, and Meiji Holdings Co.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Email: [email protected]

#Enteral Feeding Formulas Market

0 notes

healthcare00897 · 6 years ago

Text

Tissue Engineering Market 2018-2026 by Price Trend of Key Raw Materials, Key Suppliers of Raw Materials and Manufacturing Process Analysis

Tissue engineering is a scientific field majorly focused on the development of tissue and organ substitutes by controlling biophysical, biological, and/or biomechanical parameters in the laboratory. Tissue engineering has emerged as a rapidly expanding approach to address shortage of organs in transplantation procedures and is a major component of regenerative medicine. The general principles of tissue engineering involve combining living cells with a synthetic or natural support or scaffold to build a three dimensional living construct that is structurally, functionally, and mechanically equal to or better than the tissue that is to be replaced.

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2217

Increasing prevalence of kidney related disorders is expected to drive the tissue engineering market growth

Key Players:

Acelity L.P. Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet.

Detailed Segmentation:

Global Tissue Engineering Market, By Material Type:

Synthetic

Biological

Others

Global Tissue Engineering Market, By Application:

Dermal

Orthopedic

Dental

Neurology

Others

Global Tissue Engineering Market, By Region

North America

By Country:

U.S.

Canada

By Material Type:

Synthetic

Biological

Others

By Application:

Dermal

Orthopedic

Dental

Neurology

Others

Request Customization: https://www.coherentmarketinsights.com/insight/request-customization/2217

About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]

#Breast Imaging MarketBreast Imaging trendsBreast Imaging growthBreast Imaging insightsBreast Imaging outlook

0 notes

sumitchoudhari-blog · 6 years ago

Text

Radio Pharmaceutical Market by Technology & End-User - 2023 | Market Research Future

As the healthcare industry is moving towards the personalized approaches, the role of radiopharmaceutical is also increasing. The radiopharmaceutical is acting as an all-rounder radiopharmaceutical from diagnosis to treatment for various chronic diseases such as cancers and other neurological disorders, which has provided an impetus to the market. Demand for radiopharmaceuticals is growing due to raising awareness about availability of radiation and radioisotopes in medicine, particularly for diagnosis and therapy for various chronic conditions. In developed countries about one person in 50 uses diagnostic nuclear medicine every year, and the demand for therapy with radioisotopes is about one-tenth of this. Radiopharmaceuticals use radiation to provide diagnostic information about the functioning of a person's specific organs while radiotherapy can be used to treat some medical conditions, especially cancer, used to weaken or destroy particular targeted cells.

The global radiopharmaceutical market is expected to grow at a CAGR of 8.7% during the forecast period 2017–2023. The market’s growth is mainly attributed to the increasing prevalence of chronic diseases, which is creating a greater need for early diagnosis and treatment modules.

Intended Audience

· Drugs & Medical Device Manufacturers for radiopharmaceutical

· Drugs& Medical Device Suppliers for radiopharmaceutical

· Training & Service providers for radiopharmaceutical

· Research and Development (R&D) Companies

· Market Research and Consulting Service Providers

· Potential Investors

Radio Pharmaceutical Market Segmentation:

The global radiopharmaceutical market is segmented by type, type of test, application, route of administration, and end user.

By type, it is segmented into diagnostic type radiopharmaceuticals and therapeutic type radiopharmaceuticals. Diagnostic type radiopharmaceutical is further sub-segmented into SPECT radiopharmaceutical and PET radiopharmaceutical. Therapeutic type radiopharmaceutical is further sub-segmented into beta emitters, alpha emitters, brachytherapy. SPECT radiopharmaceutical is further sub-segmented into Technetium-99m, Thallium-201, Iodine-123, and others. PET radiopharmaceutical is further sub-segmented into F-18, Rubidium-82, and others. While, beta emitters are sub-segmented into Iodine-131, Yttrium-90, Samarium-153, Rhenium-186, Lutetium-177, and others. And, brachytherapy is sub-segmented into Iodine-125, Iridium-192, Cesium-131, and others.

By type of test, it is segmented into myocardial perfusion scan, lung scan, bone scan, white blood cell scan, gallium scan, renal nuclear medicine scan, parathyroid scans, hepatobiliary scans, cerebral perfusion scan and others. Whereas, a bone scan is further sub-segmented into Technetium-99m 1st, fluoride-18 2nd, and others. Myocardial Perfusion Scan, Type is sub-segmented into Technetium-99m, Thallium-201, Rubidium-82, and others. The lung scan by type is segmented into Xenon-133, Krypton-81m, and others. And, White blood cell Scan is sub-segmented into Indium-111 and others.

By application, it is segmented into oncology, cardiology, neurology, urology, and others. Oncology segment is further segmented into following applications; prostate cancer, bone cancer, breast cancer and others. Cardiology segment is further segmented into following applications; coronary artery disease, cardiomyopathy and others. Neurology segment is further segmented into following applications such as traumatic brain injury, stroke, Alzheimer’s disease and others. Urology is sub-segmented into acute pyelonephritis, congenital renal anomalies, and others.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/1650

Key Players

Some of the key players in this market are Jubilant Life Sciences Ltd., Siemens AG, Sun Pharmaceutical Industries Ltd., Bayer AG, Cardinal Health Inc., Medtronic, General Electric Company (GE Healthcare), Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., Mallinckrodt Pharmaceuticals, Nordion, Inc., Canadian Nuclear Laboratories (CNL), Bracco Diagnostic Inc., IBA Dosimetry GmbH, Avid Radiopharmaceuticals and few others.

The report offers insights on the prominent market players and gauges their current position in the market. Company information with regard to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives.

Regional Analysis

The global radiopharmaceutical market is segmented into four major regions including Americas, Europe, Asia Pacific and the Middle East & Africa. Among these, Americas and Europe will continue to present lucrative growth opportunities for market players during the forecast period. Currently, these two regions collectively account for the largest share of the market and the trend is likely to continue over the next couple of years. Higher healthcare spending and existence a robust healthcare system system in these regions is reflecting favorably on the market. In Asia Pacific, increased focus on improving the quality of healthcare services is auguring well for market players operating in the region. During the review period, the market in the region is expected to capture a strong CAGR.

Table Of Content

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Scope Of Study 27

3.2 Research Objective 27

3.3 Assumptions & Limitations 27

3.3.1 Assumptions 27

3.3.2 Limitations 27

3.4 Market Structure 27

4 Research Methodology

4.1 Primary Research 29

4.2 Secondary Research 30

4.3 Market Size Estimation 31

4.4 Forecast Model 31

TOC Continued….!

Browse Complete Report Details @

https://www.marketresearchfuture.com/reports/radio-pharmaceutical-market-1650

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email:

[email protected]

#Healthcare

0 notes

megasddw-blog · 6 years ago

Text

Radiopharmaceuticals Market Outlook and Forecast 2023: Growth Factors, Trends, and Top Companies Analysis for Business Development

MRFR is the Leading Brand in The Research Company who Recently Published Global Radiopharmaceuticals Market Research Reports which includes Study of Growth, Regional Overview, Top participants, Major Drivers and Forecast to 2023.

Radiopharmaceuticals Market - Overview

Global Radiopharmaceuticals Market to grow at a solid CAGR of 8.7% over the 2017-2023 forecast period due to the growing demand for radiopharmaceuticals in diagnostic as well as therapeutic applications in the healthcare sector.

Request Sample Copy at https://www.marketresearchfuture.com/sample_request/1650

Industry Updates:

In Q3 2018, Novartis (Advanced Accelerator Applications) acquired two new radioisotope drugs – Lu-PSMA-617 from Endocyte and FF-10158 from Fujifilm Toyama Chemical.

Competitive Players:

Leading players in the global radiopharmaceuticals market include Jubilant Life Sciences Ltd., Sun Pharmaceutical Industries Ltd., Cardinal Health Inc., GE Healthcare, Advanced Accelerator Applications SA (owned by Novartis), Nordion Inc., Bracco Diagnostic Inc., Avid Radiopharmaceuticals, IBA Dosimetry GmbH, Canadian Nuclear Laboratories, Mallinckrodt Pharmaceuticals, Lantheus Medical Imaging Inc., Medtronic, Bayer AG, and Siemens AG.

In a similar manner as X-rays, these radioisotopes help physicians diagnose a number of diseases. In contrast, radioisotopes that emit short-range particles such as alpha and beta particles are used in therapeutic applications, as short-range particles “burn up”, i.e. lose their energy, over relatively short distances, allowing spectacular results in terms of cell destruction on a highly local scale. Radioisotopes of the latter kind also stay for longer periods of time in the human body, allowing for prolonged treatment.

The growing prevalence of cancer is the primary driver for the global radiopharmaceuticals market, as cancer treatment accounts for the majority of the application of radiopharmaceuticals in the healthcare sector. Growing investment in cancer research in a number of countries round the world is likely to remain a major driver for the radiopharmaceuticals market over the forecast period, as many countries have started to take the threat of cancer seriously following a steady rise in the prevalence of many cancer types. On the other hand, the high cost of radiopharmaceuticals and the risks of using radiopharmaceuticals in therapeutic applications are likely to hamper the growth prospects of the global radiopharmaceuticals market over the forecast period.

Segmentation Analysis:

The global radiopharmaceutical market is segmented based on type, type of test, application, route of administration, end user, and region.

By type, the market for radiopharmaceuticals is segmented into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals. The diagnostics segment is further sub-segmented into SPECT radiopharmaceuticals and PET radiopharmaceuticals; the SPECT radiopharmaceuticals segment is further sub-segmented into technetium-99m, thallium-201, iodine-123, and others, while The PET radiopharmaceuticals segment is further sub-segmented into F-18, rubidium-82, and others.

The therapeutic radiopharmaceuticals segment is further sub-segmented into beta emitters, alpha emitters, and brachytherapy. The beta emitters segment is further sub-segmented into iodine-131, yttrium-90, samarium-153, rhenium-186, lutetium-177, and others. The brachytherapy segment is sub-segmented into iodine-125, iridium-192, cesium-131, and others.

Browse Complete 271 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/radio-pharmaceutical-market-1650

By type of test, the market is segmented into myocardial perfusion scan, lung scan, bone scan, white blood cell scan, gallium scan, renal nuclear medicine scan, parathyroid scans, hepatobiliary scans, cerebral perfusion scan, and others. The myocardial perfusion scan segment is further sub-segmented into technetium-99m, thallium-201, rubidium-82, and others. The lung scan segment is further sub-segmented into xenon-133, krypton-81m, and others. The bone scan segment is further sub-segmented into technetium-99m, fluoride-18, and others. The white blood cell scan segment is sub-segmented into indium-111 and others.

By application, the market is segmented into oncology, cardiology, neurology, urology, and others. The oncology segment is further segmented into prostate cancer, bone cancer, breast cancer, and others. The cardiology segment is further segmented into coronary artery disease, cardiomyopathy, and others. The neurology segment is further segmented into traumatic brain injury, stroke, Alzheimer’s disease, and others. The urology segment is sub-segmented into acute pyelonephritis, congenital renal anomalies, and others.

By route of administration, the market is segmented into oral, intravenous, and others.

By end user, the market is segmented into hospitals, diagnostic centers, research institutes, and others.

Regional Analysis:

The global radiopharmaceuticals market is segmented by geography into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas is the dominant regional segment of the global radiopharmaceuticals market and is likely to remain the leading contributor to the global market due to the high prevalence of cancer as well as other neurological and cardiovascular diseases in which radiopharmaceuticals are used in some capacity. The increasing investment in cancer research in the Americas, particularly the U.S., is likely to be a major driver for the radiopharmaceuticals market in the region over the forecast period.

Moreover, Asia Pacific is likely to be the fastest growing regional market due to the growing prevalence of cancer and the growing awareness about SPECT and PET systems.

Major TOC of Radiopharmaceutical Market Research Report – Forecast to 2023:

1 Report Prologue

2 Executive Summary

3 Market Introduction

4 Research Methodology

5 Market Dynamics

6 Market Factor Analysis

TOC CONTINUED…

List of Tables:

TABLE 1 MARKET SYNOPSIS 25

TABLE 2 GLOBAL RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014–2023 (USD MILLION) 48

TABLE 3 GLOBAL RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014–2023 (USD MILLION) 49

TABLE 4 GLOBAL RADIOPHARMACEUTICAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2014–2023 (USD MILLION) 49

TABLE 5 GLOBAL RADIOPHARMACEUTICAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2014–2023 (USD MILLION) 50

TABLE 6 GLOBAL RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC, BY TYPE, 2014–2023 (USD MILLION) 50

TABLE 7 GLOBAL RADIOPHARMACEUTICAL MARKET FOR BETA EMITTERS, BY TYPE, 2014–2023 (USD MILLION) 50

TABLE 8 GLOBAL RADIOPHARMACEUTICAL MARKET FOR BRACHYTHERAPY, BY TYPE, 2014–2023 (USD MILLION) 51

TABLE 9 GLOBAL RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC TYPE, BY REGION, 2014–2023 (USD MILLION) 51

TABLE 10 GLOBAL RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC TYPE, BY REGION, 2014–2023 (USD MILLION) 51

LOT CONTIONUED…!

To know more Updates Related Report Visit at https://www.openpr.com/news/1115880/Radiopharmaceutical-Market-2018-Renowned-Players-like-Siemens-Sun-Pharmaceutical-Industries-Cardinal-Health-Medtronic-etc-by-2023.html

About Market Research Future:

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: [email protected]

0 notes

megasddw-blog · 6 years ago

Text

Radiopharmaceuticals Market Top Players and New Trends Report 2019 - 2023

Market Research Future (MRFR) Has Launched a New Report on the Global Radiopharmaceuticals Market to provide readers with a clear view of the market’s likely growth trajectory over the coming years.